Word

HARBOUR HCAB+

Status

Dead

Status Code

602

Status Date

Thursday, August 24, 2023

Serial Number

97510185

Mark Type

4000

Filing Date

Tuesday, July 19, 2022

Abandoned Date

Friday, August 11, 2023

Trademark Owner History

Harbour Antibodies U.S., Inc.

Classifications

5 Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor

42 Technical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; medical research; biological research; Biochemical research and analysis; Testing of pharmaceuticals

Trademark Events

Aug 24, 2023

Abandonment Notice E-Mailed - Failure To Respond

Aug 24, 2023

Abandonment Notice Mailed - Failure To Respond

Aug 24, 2023

Abandonment - Failure To Respond Or Late Response

May 10, 2023

Notification Of Non-Final Action E-Mailed

May 10, 2023

Non-Final Action E-Mailed

May 10, 2023

Non-Final Action Written

May 3, 2023

Assigned To Examiner

Aug 9, 2022

New Application Office Supplied Data Entered

Jul 22, 2022

New Application Entered